SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-064791
Filing Date
2024-03-11
Accepted
2024-03-11 16:05:55
Documents
14
Period of Report
2024-03-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d786050d8k.htm   iXBRL 8-K 22484
  Complete submission text file 0001193125-24-064791.txt   143510

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20240311.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20240311_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20240311_pre.xml EX-101.PRE 11272
16 EXTRACTED XBRL INSTANCE DOCUMENT d786050d8k_htm.xml XML 3680
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 24737979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)